Mike O'Callaghan Federal Medical Center
Nellis Air Force Base, Nevada, 89191, United States
NCT Number: NCT02761018
The investigators will recruit DoD beneficiaries, aged 18 years or older and diagnosed as being Type II diabetic. Patients will be randomized into one of two groups. Group 1 will use a fitness tracker but will not be able to see other participants data and group 2 will use a fitness tracker and will be able to see other members daily and weekly results. Outcome measures will be assessed at baseline, 3 months and 6 months to include hemoglobin A1c, weight, body mass index, blood pressure, and number of hours and days fitness tracker is used. The goal is to see if the group randomized into an online community will have improved activity and outcome measurements compared with those who use the pedometer alone.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nellis Air Force Base, Nevada, 89191, United States
Male and female DoD beneficiaries ages 18 years or older who have been diagnosed with Type II diabetes, will be recruited at the Mike O'Callaghan Federal Medical Center (MOFMC).
Screening Visit:
Visit 1 (Day 1 within 1 week of Screening Visit):
Visit 2 (Month 3/90 days post Visit 1):
Final Visit 3 (Month 6/90 days post Visit 2):
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
YOU MUST BE ABLE TO GET CARE AT NELLIS AFB (A MILITARY INSTALLATION) IN ORDER TO PARTICIPATE IN THIS STUDY.
Inclusion:
Exclusion:
will use a fitness tracker but will not be able to see other participant's data
will use a fitness tracker and will be able to see other member's daily and weekly results
Time frame: 6 months
Mike O'Callaghan Military Hospital
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07084350
Diabetes Mellitus, Diabetes Mellitus, Type 2
Shenyang, Liaoning, China
View Trial DetailsNCT07107620
Diabetes Mellitus, Diabetes Mellitus, Type 2
Denizli, Turkey (Türkiye)
View Trial DetailsNCT03912363
Diabetes Mellitus, Diabetes Mellitus, Type 2
Danville, Pennsylvania, United States
View Trial DetailsNCT06652971
Diabetes Mellitus, Diabetes Mellitus, Type 2
Gangseo-gu, Seoul, South Korea
View Trial Details